PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1719995
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1719995
Bioprocess Analyzers Market size was valued at USD 2,245.12 Million in 2024, expanding at a CAGR of 13.20% from 2025 to 2032.
Bioprocess analyzers are analytical devices or systems which track, examine, and regulate various factors and procedures involved in biopharmaceutical manufacturing, bioprocessing, and biotechnology. These analyzers are used in a variety of industries to ensure the effectiveness and quality of bioprocessing activities while also allowing for real-time monitoring and control of critical parameters.
Bioprocess Analyzers Market- Market Dynamics
Impact Of Rising Demand for Biopharmaceuticals On The Bioprocess Analyzers Market
The increasing demand for biopharmaceuticals is projected to drive future expansion in the bioprocess analyzer market. Biopharmaceuticals are medications derived from biological sources, such as living organisms or their components. The biopharmaceutical sector is expanding due to innovative research and development activities that result in the production of new biologics and biosimilars. Bioprocess analyzers monitor a variety of factors during biopharmaceutical production, including cell proliferation, protein expression, and product purity. For instance, in January 2024, IQVIA, a US-based biopharmaceutical development services company, predicted that global biotech investment would top $892 billion by 2028. As a result, increased demand for biopharmaceuticals will fuel the expansion of the bioprocess analyzer market.
Bioprocess Analyzers Market- Key Insights
Our research analyst estimates that the global market will grow at a CAGR of approximately 13.20% from 2025 to 2032.
Based on Product segmentation, Consumables & accessories were predicted to show maximum market share in the year 2024
Based on Analysis Type segmentation, Substrate analysis was the leading type in 2024
Based on end use segmentation, during the forecast period, the CRO and CMO segments are expected to grow at the fastest CAGR.
Based on region, North America was the leading revenue generator in 2024
The Global Bioprocess Analyzers Market is segmented based on Product, Analysis Type, Application, End-use, and Region.
The market is divided into two categories based on Product: Instruments, and Consumables & accessories. Consumables and accessories were predicted to show the highest market share in the year 2024. The Consumables & accessories segment includes all basic materials used in bioprocess workflows, such as culture media, reagents, and other related components. Culture media provide nutrients for cell and microbial growth, whereas reagents facilitate downstream processing such as purification and quality testing. Access is defined as the availability of high-quality, pre-validated materials that facilitate operations and ensure regulatory compliance. The ongoing advancements in cell and gene therapies, as well as personalized medicine, are driving an increase in demand for tailored media formulations and innovative reagents.
The market is divided into four categories based on End-use: Biopharmaceutical companies, Research & academic institutes, CROs & CMOs, and Other End Use. The CROs and CMOs segment is expected to grow at the fastest CAGR during the forecast period, owing to pharmaceutical and biotechnology companies' increased outsourcing of research and manufacturing activities. These businesses strive to be efficient and cost-effective while still providing high-quality services to their customers. Furthermore, CROs and CMOs can provide more comprehensive services to their customers by incorporating cutting-edge bioprocess monitoring technologies such as Process Analytical Technologies (PAT) and real-time release testing. These technologies enable real-time data collection, analysis, and decision-making, ultimately leading to higher product quality and shorter development times.
Bioprocess Analyzers Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America led the Bioprocess Analyzers Market in 2024, owing to rising demand for advanced technology, increased regulatory compliance, and a focus on improving product quality. The expansion of the biopharmaceutical industry increased R&D spending, and the rise in chronic illness prevalence are all major contributors to this growth. To meet the growing demand for cutting-edge biotechnology solutions, Cytiva and Pall Corporation, for example, announced a combined USD 1.5 billion investment over two years in July 2021. As part of this initiative, new factories specializing in bioprocessing equipment will be established throughout the United States. The area's established healthcare system and strong government funding for life sciences programs are also driving market growth.
The Bioprocess Analyzers Market in Asia Pacific is projected to grow at the fastest CAGR during the forecast period. This increase is attributed to the region's growing biotechnology and pharmaceutical sectors, which are fueled by factors such as increased healthcare spending and the expansion of R&D activities. As companies in these sectors strive to improve their capabilities in drug discovery, personalized medicine, and diagnostics, there is a growing demand for cutting-edge technologies.
The bioprocess analyzers market is competitive, with both large established firms and start-ups offering advanced analytical solutions for biopharmaceutical manufacturing. Major players in the market include Agilent Technologies, Inc., SYSBIOTECH GmbH, Danaher Corporation, and Endress+Hauser Group Services AG, which use cutting-edge technologies to monitor and control bioprocesses in real time to ensure product quality and regulatory compliance. These companies invest heavily in research and development to improve the precision and efficacy of their analyzers, as well as develop new products to meet the growing demand for bioprocess optimization. Furthermore, the rapid adoption of digitalization and automation in biomanufacturing is driving competition, forcing companies to design comprehensive solutions that integrate workflows to improve overall process efficiency. For instance, in October 2023, the United States Pharmacopeia (USP) announced a new collaboration with the American Type Culture Collection (ATCC) to create a suite of joint products aimed at improving quality control for biological therapies and vaccines. As a result of this collaboration, they have introduced six innovative products, primarily focused on the detection and measurement of residual host cell DNA.
January 2023, Nova Biomedical launched the BioProfile FAST CDV, a high-throughput, fully automated analyzer for viable cell density and viability. It can deliver results in under 70 seconds with only a 100µL sample volume. This release represented a significant advancement in the field of cell analysis, giving laboratories faster and more efficient options for viable cell testing.
In May 2023, Cytiva, a Danaher Corporation subsidiary, merged with Pall Corporation's life sciences division to expand its bioprocessing portfolio. The merger combined Pall's biotech brands (Allegro, Supor, and Pegasus) with Cytiva's existing offerings (AKTA and Xcellerex). Danaher's leadership in life sciences was strengthened as a result of this transaction, which expanded its bioprocessing capabilities and accelerated therapeutic development.
In September 2022, 908 Devices, a chemical and biochemical analysis company based in the United States, acquired TRACE Analytics for $15.3 million. The agreement will help 908 Devices strengthen its bioanalytics platform by allowing it to take a measurable step toward developing a connected and comprehensive platform. TRACE Analytics is a bioprocess analyzer manufacturer and supplier based in the United States that offers online analytical technologies for bioprocess research, development, and production.